Cantor Fitzgerald Reiterates Overweight Rating on Lucid Diagnostics Inc (LUCD) Aug 19, 2025 07:07AM
Cantor Fitzgerald Reiterates Overweight Rating on Lucid Diagnostics Inc (LUCD) May 19, 2025 06:43AM
Cantor Fitzgerald Reiterates Overweight Rating on Lucid Diagnostics Inc (LUCD) May 14, 2025 04:38PM
Cantor Fitzgerald Reiterates Overweight Rating on Lucid Diagnostics Inc (LUCD) Mar 26, 2025 06:46AM
Cantor Fitzgerald newsletter says Elutia best, Anteris worst performer Mar 17, 2025 07:38AM


Nov 15, 2024 06:41AM Lucid Diagnostics Inc (LUCD) PT Lowered to $2 at Cantor Fitzgerald
Aug 13, 2024 02:57PM Cantor Fitzgerald Positive on Lucid Diagnostics Inc (LUCD) Following Earnings
Nov 14, 2023 02:31PM Lucid Diagnostics Inc (LUCD) PT Lowered to $3.80 at Cantor Fitzgerald
Sep 21, 2023 08:30AM PAVmed and Lucid Diagnostics to Participate in Panel Presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference
Nov 15, 2022 04:20PM PAVmed Provides Business Update and Third Quarter 2022 Financial Results
Nov 14, 2022 04:40PM Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results
May 12, 2022 04:38PM PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results
May 11, 2022 04:00PM Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results
Apr 27, 2022 09:46AM Cantor Fitzgerald Reiterates Overweight Rating, $12 Price Target on Lucid Diagnostics Inc (LUCD) on BeiGene's RATIONALE 306 Trial Data, "Encourage Investors to Acquire LUCD Shares at an Attractive Ent
Mar 29, 2022 04:11PM PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
Mar 29, 2022 07:45AM Cantor Fitzgerald Reiterates Overweight Rating and $12 PT on Lucid Diagnostics (LUCD), "We Encourage Investors to Acquire LUCD Shares at Attractive Valuation"
Mar 28, 2022 04:50PM Lucid Diagnostics Inc (LUCD) Provides Business Update, Reports Prelim Q4
Mar 28, 2022 04:47PM Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
Mar 23, 2022 09:55AM Cantor Fitzgerald Reiterates Overweight Rating on Lucid Diagnostics Inc (LUCD), Sees Launch in Three New Areas as Favorable and as an Important Commercialization Milestone
Nov 8, 2021 06:21AM UPDATE: Cantor Fitzgerald Starts Lucid Diagnostics Inc (LUCD) at Overweight
Oct 18, 2021 06:09PM Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
Oct 18, 2021 05:45PM Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
Oct 18, 2021 05:45PM Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
Oct 14, 2021 05:43AM Lucid Diagnostics Inc (LUCD) Prices 5M Share IPO at $14/sh
Oct 13, 2021 10:15PM Lucid Diagnostics Announces Pricing of Initial Public Offering
Oct 13, 2021 10:15PM Lucid Diagnostics Announces Pricing of Initial Public Offering
Oct 13, 2021 09:28PM Lucid Diagnostics Announces Pricing of Initial Public Offering